Ensign Peak Advisors’s X4 Pharmaceuticals XFOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,235,655
| Closed | -$529K | – | 1725 |
|
|
2025
Q1 | $529K | Sell |
2,235,655
-310,803
| -12% | -$73.5K | ﹤0.01% | 1534 |
|
|
2024
Q4 | $1.87M | Hold |
2,546,458
| – | – | ﹤0.01% | 968 |
|
|
2024
Q3 | $1.7M | Hold |
2,546,458
| – | – | ﹤0.01% | 1020 |
|
|
2024
Q2 | $1.48M | Buy |
2,546,458
+111,032
| +5% | +$64.4K | ﹤0.01% | 1043 |
|
|
2024
Q1 | $3.39M | Buy |
+2,435,426
| New | +$3.39M | 0.01% | 762 |
|
|
2022
Q2 | – | Sell |
-176,530
| Closed | -$309K | – | 2208 |
|
|
2022
Q1 | $309K | Hold |
176,530
| – | – | ﹤0.01% | 1740 |
|
|
2021
Q4 | $404K | Buy |
176,530
+147,937
| +517% | +$339K | ﹤0.01% | 1699 |
|
|
2021
Q3 | $151K | Hold |
28,593
| – | – | ﹤0.01% | 1773 |
|
|
2021
Q2 | $186K | Hold |
28,593
| – | – | ﹤0.01% | 1731 |
|
|
2021
Q1 | $246K | Sell |
28,593
-1,469
| -5% | -$12.6K | ﹤0.01% | 1707 |
|
|
2020
Q4 | $193K | Sell |
30,062
-10,105
| -25% | -$64.9K | ﹤0.01% | 1731 |
|
|
2020
Q3 | $272K | Buy |
40,167
+34,038
| +555% | +$230K | ﹤0.01% | 1639 |
|
|
2020
Q2 | $57K | Hold |
6,129
| – | – | ﹤0.01% | 1657 |
|
|
2020
Q1 | $61K | Sell |
6,129
-6,129
| -50% | -$61K | ﹤0.01% | 1598 |
|
|
2019
Q4 | $131K | Buy |
+12,258
| New | +$131K | ﹤0.01% | 1636 |
|